Class 4 Caution in Use
Pfizer Limited has notified us of a manufacturing defect in the dosing mechanism of some Genotropin GoQuick pens which are used to administer somatropin.
Please visit the: MHRA website for more details on this drug alert.
The affected products' details are as follows:
PIP Code | Product Description | Supplier | Affected Batch |
---|---|---|---|
3568979 | Genotropin Goquick 12mg | Pfizer Ltd | All unexpired batches |
3568961 | Genotropin Goquick 5.3mg | Pfizer Ltd | All unexpired batches |
This is a caution in use only and therefore we are not accepting stock returns.
Please contact Pfizer's endocrine helpline, tel 0800 521249; email endocrinecare@pfizer.com
Alternatively contact Pfizer Medical Information, tel 01304 616161
Recipients of this Drug Alert should bring it to the attention of relevant contacts.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
If you have any questions, then please contact your local Service Centre Customer Services team.